SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-15-033273
Filing Date
2015-05-01
Accepted
2015-05-01 17:43:21
Documents
1
Period of Report
2015-04-29

Document Format Files

Seq Description Document Type Size
1 3/A a3a.html 3/A  
1 3/A a3a.xml 3/A 2438
  Complete submission text file 0001104659-15-033273.txt   3781
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-374-7580
Blueprint Medicines Corp (Issuer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address BLUEPRINT MEDICINES CORP. 215 FIRST STREET, SUITE 340/350 CAMBRIDGE MA 02142
Business Address
Lengauer Christoph (Reporting) CIK: 0001638469 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-37359 | Film No.: 15825735